{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:34:35Z","timestamp":1791048875223,"version":"4.1.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.ctrv.2009.10.002","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T05:26:30Z","timestamp":1258003590000},"page":"43-53","source":"Crossref","is-referenced-by-count":162,"title":["Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma"],"prefix":"10.1016","volume":"36","author":[{"given":"Anupam","family":"Bishayee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Themos","family":"Politis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altaf S.","family":"Darvesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2009.10.002_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctrv.2009.10.002_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2005-871194","article-title":"Hepatocellular carcinoma: epidemiology, risk factors, and screening","volume":"25","author":"Sherman","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ctrv.2009.10.002_bib3","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1053\/j.gastro.2004.09.013","article-title":"Hepatocellular carcinoma: recent trends in the United States","volume":"127","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctrv.2009.10.002_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctrv.2009.10.002_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0168-8278(00)80428-6","article-title":"Hepatocellular carcinoma","volume":"32","author":"Okuda","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib6","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/carcin\/5.11.1381","article-title":"Relevance of nitrosamines to human cancer","volume":"5","author":"Bartsch","year":"1984","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ctrv.2009.10.002_bib7","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.1053\/j.gastro.2004.09.046","article-title":"Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas","volume":"127","author":"Kensler","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctrv.2009.10.002_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2005.08.031","article-title":"Molecular pathways in hepatocellular carcinoma","volume":"240","author":"Pang","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ctrv.2009.10.002_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jhep.2008.04.016","article-title":"The influence of alcohol consumption and hepatitis B and C infections on the risk of liver cancer in Europe","volume":"49","author":"Ribes","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib10","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"Llovet","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2009.10.002_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ctrv.2009.10.002_bib12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1470-2045(09)70222-0","article-title":"Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and mata-analysis of clinical trials","volume":"10","author":"Je","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib13","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1046\/j.1440-1746.2001.02634.x","article-title":"Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives","volume":"16","author":"Okuno","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc1076","article-title":"Translational strategies for cancer prevention in liver","volume":"3","author":"Kensler","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2009.10.002_bib15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2007.11.007","article-title":"Inflammation, HCC and sex: IL-6 in the centre of the triangle","volume":"48","author":"Prieto","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ctrv.2009.10.002_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1749-6632.2009.03704.x","article-title":"Inflammation and liver cancer: new molecular links","volume":"1155","author":"Berasain","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ctrv.2009.10.002_bib18","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1038\/sj.onc.1209547","article-title":"Genetics of hepatocellular tumors","volume":"25","author":"Laurent-Puig","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ctrv.2009.10.002_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1515\/BC.2006.049","article-title":"Oxidative stress and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis","volume":"387","author":"Kawanishi","year":"2006","journal-title":"Biol Chem"},{"key":"10.1016\/j.ctrv.2009.10.002_bib20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.21802","article-title":"Nuclear factor-(B and the hepatic inflammation\u2013fibrosis\u2013cancer axis","volume":"46","author":"Elsharkawy","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ctrv.2009.10.002_bib21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/cr.2008.30","article-title":"The I(B kinase \u2013 a bridge between inflammation and cancer","volume":"18","author":"Karin","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jat.1393","article-title":"NF-(B in liver diseases: a target for drug therapy","volume":"29","author":"Muriel","year":"2009","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1089\/ars.2006.8.1249","article-title":"Redox signaling in cancer biology","volume":"8","author":"Gius","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.ctrv.2009.10.002_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.pharmtox.44.101802.121851","article-title":"The oxidative stress in carcinogenesis","volume":"44","author":"Klaunig","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib25","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR; 2007."},{"key":"10.1016\/j.ctrv.2009.10.002_bib26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/ars.2007.1740","article-title":"Cancer chemoprevention through dietary antioxidants: progress and promise","volume":"10","author":"Khan","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.ctrv.2009.10.002_bib27","first-page":"187","article-title":"Food as medicine: potential therapeutic tendencies of plant derived polyphenolic compounds","volume":"9","author":"Ullah","year":"2008","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ctrv.2009.10.002_bib28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mnfr.200700326","article-title":"Cancer chemoprevention and chemotherapy: dietary polyphenols and signaling pathways","volume":"52","author":"Ramos","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib29","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.2174\/092986709789352312","article-title":"Plant polyphenols and tumors: from mechanisms to therapies, prevention, and protection against toxicity of anti-cancer treatments","volume":"16","author":"Korkina","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ctrv.2009.10.002_bib30","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.bcp.2006.07.004","article-title":"Regulation of inflammation and redox signaling by dietary polyphenols","volume":"72","author":"Rahman","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1158\/1940-6207.CAPR-08-0141","article-title":"Bioactive food components, inflammatory targets, and cancer prevention","volume":"2","author":"Kim","year":"2009","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/CEJ.0b013e3282f0c090","article-title":"Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis","volume":"18","author":"Mann","year":"2009","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.ctrv.2009.10.002_bib33","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.4161\/cc.7.8.5740","article-title":"Resveratrol: a multitargeted agent for age-associated chronic diseases","volume":"7","author":"Harikumar","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ctrv.2009.10.002_bib34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","article-title":"Therapeutic potential of resveratrol: the in vivo evidence","volume":"5","author":"Baur","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ctrv.2009.10.002_bib35","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.2741\/2432","article-title":"Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential","volume":"12","author":"Shankar","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.ctrv.2009.10.002_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mnfr.200800148","article-title":"Resveratrol addiction: to die or not to die","volume":"53","author":"Shakibaei","year":"2009","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib37","first-page":"217","article-title":"Significance of wine and resveratrol in cardiovascular disease: French paradox revisited","volume":"11","author":"Vidavalur","year":"2006","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1365\/s10337-009-1132-x","article-title":"Determination of flavonoids and resveratrol in wine by turbulent-flow chromatography\u2013LC\u2013MS","volume":"69","author":"Presta","year":"2009","journal-title":"Chromatographia"},{"key":"10.1016\/j.ctrv.2009.10.002_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mrrev.2007.08.004","article-title":"Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?","volume":"658","author":"Saiko","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1753-4887.2008.00076.x","article-title":"Potential of resveratrol in anticancer and anti-inflammatory therapy","volume":"66","author":"Udenigwe","year":"2008","journal-title":"Nutr Rev"},{"key":"10.1016\/j.ctrv.2009.10.002_bib41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/iub.47","article-title":"Resveratrol: one molecule, many targets","volume":"60","author":"Pirola","year":"2008","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ctrv.2009.10.002_bib42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.abb.2009.01.018","article-title":"Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms","volume":"486","author":"Athar","year":"2009","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.ctrv.2009.10.002_bib43","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.275.5297.218","article-title":"Cancer chemopreventive activity of resveratrol, a natural product derived from grapes","volume":"275","author":"Jang","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2009.10.002_bib44","first-page":"2783","article-title":"Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies","volume":"24","author":"Aggarwal","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib45","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.1745-7254.2007.00690.x","article-title":"Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals","volume":"28","author":"Howells","year":"2007","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.ctrv.2009.10.002_bib46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.canlet.2008.03.057","article-title":"Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives","volume":"269","author":"Kundu","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ctrv.2009.10.002_bib47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/13880200802116610","article-title":"Resveratrol as an inhibitor of carcinogenesis","volume":"46","author":"Pezzuto","year":"2008","journal-title":"Pharm Biol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1158\/1940-6207.CAPR-08-0160","article-title":"Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials","volume":"2","author":"Bishayee","year":"2009","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib49","first-page":"51","article-title":"Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats","volume":"24","author":"Bertelli","year":"1998","journal-title":"Drug Expt Clin Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib50","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/S0024-3205(03)00096-1","article-title":"Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration","volume":"72","author":"Vitrac","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.ctrv.2009.10.002_bib51","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00726-005-0205-x","article-title":"Synthesis and biodistribution of an18 F-labelled resveratrol derivative for small animal positron emission tomography","volume":"29","author":"Gester","year":"2005","journal-title":"Amino Acids"},{"key":"10.1016\/j.ctrv.2009.10.002_bib52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1079\/BJN20061810","article-title":"Distribution of [3H]trans-resveratrol in rat tissues following oral administration","volume":"96","author":"Abd El-Mohsen","year":"2006","journal-title":"Brit J Nutr"},{"key":"10.1016\/j.ctrv.2009.10.002_bib53","first-page":"5707","article-title":"Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor","volume":"58","author":"Ciolino","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/bbrc.1999.1152","article-title":"Resveratrol is a selective human cytochrome P450 1A1 inhibitor","volume":"262","author":"Chun","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ctrv.2009.10.002_bib55","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.lfs.2004.10.039","article-title":"Toxicogenomics of resveratrol in rat liver","volume":"76","author":"Hebbar","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.ctrv.2009.10.002_bib56","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.fct.2008.11.040","article-title":"Alteration of xenobiotic metabolizing enzymes by resveratrol in liver and lung of CD1 mice","volume":"47","author":"Canistro","year":"2009","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib57","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2174\/187152807781696464","article-title":"Anti-inflammatory responses of resveratrol","volume":"6","author":"Das","year":"2007","journal-title":"Inflammation Allergy Drug Target"},{"key":"10.1016\/j.ctrv.2009.10.002_bib58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejphar.2008.06.067","article-title":"Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes","volume":"591","author":"Rubiolo","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib59","first-page":"847","article-title":"Inhibitor effect of resveratrol on the proliferation of human and rat hepatic derived cell lines","volume":"7","author":"Delmas","year":"2000","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ctrv.2009.10.002_bib60","first-page":"83","article-title":"Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells","volume":"19","author":"DeL\u0117dinghen","year":"2001","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3835(01)00476-1","article-title":"Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action","volume":"167","author":"Kozuki","year":"2001","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ctrv.2009.10.002_bib62","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10585-004-2698-1","article-title":"Resveratrol inhibits hepatoma cell invasion by suppressing gene expression on hepatocyte growth factor via its reactive oxygen species-scavenging property","volume":"25","author":"Miura","year":"2004","journal-title":"Clin Exp Metas"},{"key":"10.1016\/j.ctrv.2009.10.002_bib63","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1158\/1535-7163.MCT-05-0198","article-title":"Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1\u03b1 and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells","volume":"10","author":"Zhang","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ctrv.2009.10.002_bib64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0024-3205(02)02177-X","article-title":"Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells","volume":"72","author":"Kuo","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.ctrv.2009.10.002_bib65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF02976629","article-title":"Cytotoxic and antimutagenic stilbenes from seeds of Paeonia lactiflora","volume":"3","author":"Kim","year":"2002","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib66","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijheh.2005.01.021","article-title":"Chemopreventive properties of trans-resveratrol against the cytotoxicity of chloroacetanilide herbicides in vitro","volume":"208","author":"Kocsis","year":"2005","journal-title":"Int J Hyg Environ Health"},{"key":"10.1016\/j.ctrv.2009.10.002_bib67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3748\/wjg.v8.i1.79","article-title":"Anti-hepatoma activity of resveratrol in vitro","volume":"8","author":"Sun","year":"2002","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib68","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tox.2006.05.014","article-title":"Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells","volume":"225","author":"Michels","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.ctrv.2009.10.002_bib69","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2184.2006.00406.x","article-title":"Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells","volume":"39","author":"Stervbo","year":"2006","journal-title":"Cell Prolif"},{"key":"10.1016\/j.ctrv.2009.10.002_bib70","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.bbagen.2006.09.010","article-title":"Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation","volume":"1760","author":"Notas","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ctrv.2009.10.002_bib71","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.biopha.2007.09.006","article-title":"Resveratrol inhibits tumor necrosis factor-\u03b1-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells","volume":"62","author":"Yu","year":"2008","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ctrv.2009.10.002_bib72","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00000478-200403000-00008","article-title":"Caveolin and thrombospondin expression during hepatocellular carcinogenesis","volume":"28","author":"Yerian","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1479-5876-7-22","article-title":"Caveolin-I enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model","volume":"7","author":"Yang","year":"2009","journal-title":"J Transl Med"},{"key":"10.1016\/j.ctrv.2009.10.002_bib74","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.biochi.2008.06.006","article-title":"Antiproliferative activities of resveratrol and related compounds in human hepatocyte derived HepG2 cells are associated with biochemical cell disturbance revealed by fluorescence analyses","volume":"90","author":"Colin","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.ctrv.2009.10.002_bib75","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","article-title":"Cholangiocarcinoma","volume":"366","author":"Khan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2009.10.002_bib76","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1478-3231.2008.01749.x","article-title":"Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line","volume":"28","author":"Roncoroni","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.ctrv.2009.10.002_bib77","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1006\/bbrc.1998.9916","article-title":"Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model","volume":"254","author":"Carb\u00f3","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ctrv.2009.10.002_bib78","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0024-3205(03)00469-7","article-title":"Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats","volume":"73","author":"Miura","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.ctrv.2009.10.002_bib79","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3748\/wjg.v9.i7.1474","article-title":"Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb\/c mice","volume":"9","author":"Liu","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib80","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3748\/wjg.v9.i10.2341","article-title":"Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer","volume":"9","author":"Yu","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib81","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.3748\/wjg.v10.i20.3048","article-title":"Effect of resveratrol and in combination with 5-FU on murine liver cancer","volume":"10","author":"Wu","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib82","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/emm.2003.49","article-title":"Grape extracts suppress the formation of preneoplastic foci and activity of fatty acid synthase in rat liver","volume":"35","author":"Kweon","year":"2003","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.ctrv.2009.10.002_bib83","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.fct.2008.08.023","article-title":"Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3\u2032,4,4\u2032-tetrachlorobiphenyl (PCB-77)","volume":"46","author":"Tharappel","year":"2008","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib84","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/bjc.1995.236","article-title":"Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted with phenobarbital","volume":"71","author":"Bishayee","year":"1995","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.ctrv.2009.10.002_bib85","first-page":"41","article-title":"Characterization of selective induction and alteration of xenobiotic biotransforming enzymes by vanadium during diethylnitrosamine-induced chemical rat liver carcinogenesis","volume":"11","author":"Bishayee","year":"1999","journal-title":"Oncol Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib86","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1207\/S15327914NC3701_12","article-title":"Further evidence for chemopreventive potential of \u03b2-carotene against experimental hepatocarcinogenesis: diethylnitrosamine-initiated and phenobarbital promoted hepatocarcinogenesis is prevented more effectively by \u03b2-carotene than by retinoic acid","volume":"37","author":"Bishayee","year":"2000","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.ctrv.2009.10.002_bib87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cbi.2008.11.015","article-title":"Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis","volume":"179","author":"Bishayee","year":"2009","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.ctrv.2009.10.002_bib88","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0092-8674(95)90127-2","article-title":"Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2","volume":"83","author":"Tsujii","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ctrv.2009.10.002_bib89","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3177\/jnsv.50.61","article-title":"Resveratrol inhibits N-nitrodiethylamine-induced ornithine decarboxylase and cyclooxynegase in mice","volume":"50","author":"Khanduja","year":"2004","journal-title":"J Nutr Sci Vitaminol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib90","doi-asserted-by":"crossref","unstructured":"Luther DL, Ohanyan V, Shamhart PE, et al. Chemopreventive doses of resveratrol do not affect cardiac function in a rodent model of hepatocellular carcinoma. Invest New Drugs, in press. doi:10.1007\/S10637-009-9332-7.","DOI":"10.1007\/s10637-009-9332-7"},{"key":"10.1016\/j.ctrv.2009.10.002_bib91","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jn\/132.2.257","article-title":"The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful","volume":"132","author":"Juan","year":"2002","journal-title":"J Nutr"},{"key":"10.1016\/j.ctrv.2009.10.002_bib92","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/toxsci\/kfh263","article-title":"Resveratrol-associated renal toxicity","volume":"82","author":"Crowell","year":"2004","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.ctrv.2009.10.002_bib93","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.fct.2006.07.015","article-title":"Ontogenicity evaluation of resveratrol in p53(\u00b1) (p53 knockout) mice","volume":"45","author":"Horn","year":"2007","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib94","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.freeradbiomed.2008.12.016","article-title":"Elevation of oxidative-damage biomarkers during aging in F2 hybrid mice: protection by chronic oral intake of resveratrol","volume":"46","author":"Wong","year":"2009","journal-title":"Free Rad Biol Med"},{"key":"10.1016\/j.ctrv.2009.10.002_bib95","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.fct.2009.06.002","article-title":"Safety studies conducted on high-purity trans-resveratrol in experimental animals","volume":"47","author":"Williams","year":"2009","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib96","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-4347(01)00142-6","article-title":"Ultrasensitivity assay for the three polyphenols (catechin, quercetin and resveratrol) and their conjugates in biological fluids utilizing gas chromatography with mass selective detection","volume":"757","author":"Soleas","year":"2001","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ctrv.2009.10.002_bib97","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0009-9120(02)00397-1","article-title":"Absorption of three wine-related polyphenols in three different matrices by healthy subjects","volume":"36","author":"Goldberg","year":"2003","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ctrv.2009.10.002_bib98","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1124\/dmd.104.000885","article-title":"High absorption but very low bioavailability of oral resveratrol in humans","volume":"32","author":"Walle","year":"2004","journal-title":"Drug Metab Disp"},{"key":"10.1016\/j.ctrv.2009.10.002_bib99","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1021\/jf030582e","article-title":"Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice","volume":"52","author":"Meng","year":"2004","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.ctrv.2009.10.002_bib100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jchromb.2006.10.017","article-title":"Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography","volume":"848","author":"Boocock","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ctrv.2009.10.002_bib101","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1158\/1055-9965.EPI-07-0022","article-title":"Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent","volume":"16","author":"Boocock","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ctrv.2009.10.002_bib102","doi-asserted-by":"crossref","first-page":"564","DOI":"10.5414\/CPP46564","article-title":"Effect of food on the pharmacokinetic profile of trans-resveratrol","volume":"46","author":"Vaz-da-Silva","year":"2008","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ctrv.2009.10.002_bib103","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/mnfr.200800177","article-title":"Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers","volume":"53","author":"Almeida","year":"2009","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib104","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/mnfr.200500002","article-title":"Bioavailability of trans-resveratrol from red wine in humans","volume":"49","author":"Vitaglione","year":"2005","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib105","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1373\/clinchem.2005.065870","article-title":"Diagnostic performance of urinary resveratrol metabolites as a biomarker of moderate wine consumption","volume":"52","author":"Zamora-Ros","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.ctrv.2009.10.002_bib106","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/mnfr.200700290","article-title":"Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C\/O-conjugated diglucuronides \u2013 two novel resveratrol metabolites in human plasma","volume":"52","author":"Burkon","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib107","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/00498250500354253","article-title":"Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT 1A1 and SULT 1E1","volume":"35","author":"Miksits","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ctrv.2009.10.002_bib108","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1211\/jpp.58.4.0006","article-title":"Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms","volume":"58","author":"Brill","year":"2006","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib109","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1055\/s-2008-1074516","article-title":"Resveratrol from red grapes \u2013 pedestrian polyphenol or useful anticancer agent?","volume":"74","author":"Gescher","year":"2009","journal-title":"Planta Med"},{"key":"10.1016\/j.ctrv.2009.10.002_bib110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.aca.2008.12.003","article-title":"Simple spectrophotometric assessment of the trans-\/cis-resveratrol ratio in aqueous solutions","volume":"634","author":"Camont","year":"2009","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.ctrv.2009.10.002_bib111","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mrrev.2008.03.002","article-title":"Inflammation: gearing the journey to cancer","volume":"659","author":"Kundu","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib112","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/01635580701268188","article-title":"Inhibition of gap junctional intercellular communication and activation of mitogen-activated protein kinase by tumor-promoting organic peroxides and protection by resveratrol","volume":"57","author":"Upham","year":"2007","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.ctrv.2009.10.002_bib113","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jnutbio.2008.01.008","article-title":"Resveratrol counteracts gallic acid-induced down-regulation of gap-junction intercellular communication","volume":"20","author":"Kim","year":"2009","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.ctrv.2009.10.002_bib114","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.4161\/cc.6.20.4815","article-title":"Resveratrol: from basic science to the clinic","volume":"6","author":"Cucciolla","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ctrv.2009.10.002_bib115","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1055\/s-2008-1074553","article-title":"Mechanisms of cancer chemopreventive agents: a perspective","volume":"74","author":"Francy-Guilford","year":"2008","journal-title":"Planta Med"},{"key":"10.1016\/j.ctrv.2009.10.002_bib116","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1055\/s-0029-1185533","article-title":"Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells","volume":"75","author":"Miksits","year":"2009","journal-title":"Planta Med"},{"key":"10.1016\/j.ctrv.2009.10.002_bib117","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ijc.20884","article-title":"Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4\u2032-tetramethoxystilbene (DMU-212) on adenoma development in the Apc Min\/+ mouse and cycloooygenase-2 in human-derived colon cancer cells","volume":"115","author":"Sale","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2009.10.002_bib118","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/carcin\/bgl055","article-title":"Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities","volume":"27","author":"Lee","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ctrv.2009.10.002_bib119","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1078-0432.CCR-06-1528","article-title":"Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats","volume":"13","author":"Suh","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2009.10.002_bib120","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00280-007-0414-y","article-title":"Vaticanol C, a novel resveratrol tetramer, reduces lymph node and lung metastases of mouse mammary carcinoma carrying p53 mutation","volume":"60","author":"Shibata","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ctrv.2009.10.002_bib121","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/mc.20352","article-title":"Antitumor activity of 3,5,4(-trimethoxystilbene in COLO 205 cells and xenografts in SCID mice","volume":"47","author":"Pan","year":"2008","journal-title":"Mol Carcinog"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737209001558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737209001558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:04:55Z","timestamp":1558627495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737209001558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0305737209001558"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2009.10.002","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}